MEDICAL SERVICES

EDUCATION

Undergraduate Degree

  • University of Michigan , Ann Arbor , MI

Graduate Degree

  • University of Washington , Seattle , WA

Medical School

  • University of Washington , Seattle , WA

Residency

  • Boston Combined Residency Program (BCRP) , Boston , MA

Residency

  • Boston Combined Residency Program (BCRP) , Boston , MA

Fellowship

  • Boston Children's Hospital , Boston , MA

CERTIFICATIONS

  • American Board of Pediatrics, Pediatric Cardiology
  • American Board of Pediatrics, General Pediatrics

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Sustained Activation of AMPK Enhances Differentiation of Human iPSC-Derived Cardiomyocytes via Sirtuin Activation. Stem Cell Reports. 2020 08 11; 15(2):498-514. View abstract
  2. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions. Trends Cardiovasc Med. 2021 Feb; 31(2):85-90. View abstract
  3. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Transplantation. 2020 01; 104(1):e31-e37. View abstract
  4. Steady-state and regenerative hematopoiesis occurs normally in mice in the absence of GDF11. Blood. 2019 11 14; 134(20):1712-1716. View abstract
  5. Inhibition of mTOR Signaling Enhances Maturation of Cardiomyocytes Derived From Human-Induced Pluripotent Stem Cells via p53-Induced Quiescence. Circulation. 2020 01 28; 141(4):285-300. View abstract
  6. Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities. Chem Rev. 2019 11 13; 119(21):11352-11390. View abstract
  7. Analysis of Cre-mediated genetic deletion of Gdf11 in cardiomyocytes of young mice. . 2019 07 01; 317(1):H201-H212. View abstract
  8. Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis. J Mol Cell Cardiol. 2019 03; 128:179-186. View abstract
  9. Engineering of mature human induced pluripotent stem cell-derived cardiomyocytes using substrates with multiscale topography. Advanced Functional Materials. 2018; 19(28):1707378. View abstract
  10. Into the hearts of babes: Stem cell therapy for pediatric heart failure. J Heart Lung Transplant. 2017 08; 36(8):830-832. View abstract
  11. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? Circ Heart Fail. 2016 Jan; 9(1):e002328. View abstract
  12. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell. 2013 Jun 06; 12(6):689-98. View abstract
  13. Model systems for cardiovascular regenerative biology. Cold Spring Harb Perspect Med. 2013 Apr 01; 3(4):a014019. View abstract
  14. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials. 2011 Mar; 32(9):2407-16. View abstract
  15. Injectable pH- and temperature-responsive poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors. Biomacromolecules. 2010 Jul 12; 11(7):1833-9. View abstract
  16. Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats. Clin Exp Hypertens. 2005 Jan; 27(1):71-82. View abstract
  17. Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng. 2004 Jan-Feb; 10(1-2):63-71. View abstract